SCHEMBL17777742

SCHEMBL17777742

Clc1ccc(-c2cccc3c2c2ccccc2n3-c2cccc(-c3ccccc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ MAPK14 Q16539 1/20 0.39
▸ CCNA2 P20248 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ PTGDR2 Q9Y5Y4 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ CNR1 P21554 2/20 0.37
▸ BMX P51813 1/20 0.37
▸ DNM1 Q05193 2/20 0.37
▸ GRM5 P41594 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17777421 0.92 KDM4E (0.49) KDM4EATML3MBTL1CYP1A2MAPK14
SCHEMBL30007178 0.92 KDM4E (0.49) KDM4EATML3MBTL1CYP1A2MAPK14
SCHEMBL25585066 0.91 MAPK14 (0.38) KDM4EATML3MBTL1CYP1A2MAPK14
SCHEMBL17777577 0.91 KDM4E (0.43) KDM4EATML3MBTL1CYP1A2MAPK14
SCHEMBL17714853 0.90 KDM4E (0.50) KDM4EATML3MBTL1CYP1A2MAPK14
SCHEMBL30466673 0.90 KDM4E (0.50) KDM4EATML3MBTL1CYP1A2MAPK14
SCHEMBL17777423 0.90 ATM (0.44) KDM4EATML3MBTL1MAPK14MEN1
SCHEMBL19997897 0.90 MAPK14 (0.39) KDM4EATML3MBTL1MAPK14PTGDR2
SCHEMBL30257606 0.90 CYP1A2 (0.40) KDM4ECYP1A2MAPK14PTGDR2CNR1
SCHEMBL26191632 0.90 L3MBTL1 (0.40) KDM4EATML3MBTL1CYP1A2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10957859-B2 Heterocyclic compounds for use in electronic devices MERCK PATENT GMBH (DE) 2021-03-23 — — US disclosed
US-20170324038-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-11-09 — — US disclosed
US-20170324038-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-11-09 — — US disclosed
WO-2016078747-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-05-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170324038-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES DDT, VDAC2, VDAC3 KDM4E 2237/4885ATM 4659/4885L3MBTL1 2548/4885
US-10957859-B2 Heterocyclic compounds for use in electronic devices DDT, VDAC2, VDAC3 KDM4E 2237/4885ATM 4659/4885L3MBTL1 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback